Suzhou Immunofoco Biotechnology Co., Ltd

This study compares an experimental treatment called IMC002 against standard treatments for advanced stomach cancer that has spread and cannot be surgically removed. It's for patients whose cancer has a specific marker called CLDN18.2 and who have already tried at least two other…

This early-phase study is testing a new cell therapy called IMV102 in patients with multiple myeloma that has returned or stopped responding to other treatments. The research will check if the treatment is safe and if it helps control the cancer. About 30 patients who have alread…

This early-stage study is testing a new cell therapy called IMV101 in adults whose B-cell non-Hodgkin lymphoma has come back or hasn't responded to at least two prior treatments. The main goals are to find a safe dose and see if the therapy shows early signs of fighting the cance…